Javier Castillo‐Olivares

A Modified Vaccinia Ankara Virus (MVA) Vaccine Expressing African Horse Sickness Virus (AHSV) VP2 Protects Against AHSV Challenge in an IFNAR −/− Mouse Model

Javier Castillo‐Olivares, Eva Calvo-Pinilla, Isabel Casanova et al. · PLoS ONE · 2011 · 64 citations · Full text

Vaccination, Veterinary Vaccine, Vaccine Development +11

Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge

Berta Alberca, Katarzyna Bachanek‐Bankowska, Marta Cabana et al. · Vaccine · 2014 · 52 citations · Full text

Protection of IFNAR (−/−) Mice against Bluetongue Virus Serotype 8, by Heterologous (DNA/rMVA) and Homologous (rMVA/rMVA) Vaccination, Expressing Outer-Capsid Protein VP2

Tamara Jabbar, Eva Calvo-Pinilla, Francisco Mateos et al. · PLoS ONE · 2013 · 50 citations · Full text

Viral Pathogenesis, Immunology, Immune System +17

Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study

Ana Atti, Ferdinando Insalata, Edward J Carr et al. · Journal of Infection · 2022 · 47 citations · Full text

Induction of Antibody Responses to African Horse Sickness Virus (AHSV) in Ponies after Vaccination with Recombinant Modified Vaccinia Ankara (MVA)

Rachael Chiam, Emma L. Sharp, Sushila Maan et al. · PLoS ONE · 2009 · 46 citations · Full text